Teriparatide

Brand name: Forteo

Rank #114 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$153.9M

Total Cost

Share:

38,259

Total Claims

$153.9M

Total Cost

1,665

Prescribers

$4,024

Cost per Claim

1,051

Beneficiaries

39,714

30-Day Fills

$92K

Avg Cost/Provider

23

Avg Claims/Provider

Share of Medicare Part D Spending

0.06%

of total Medicare Part D spending

$153.9M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $153.9M total

🔎 Data Overview

💰

At $4,024 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

👤

Average cost of $146,476 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Teriparatide

#ProviderSpecialtyLocationClaimsCost
1Madhumathi RaoNephrologyLexington, KY516$2.2M
2Braden BarnettEndocrinologyLos Angeles, CA319$1.4M
3Nedda HughesPhysician AssistantLexington, KY220$938K
4Barry EibschutzRheumatologySan Luis Obispo, CA180$851K
5Muhammad ShamimInternal MedicineBrownsville, TX176$793K
6Betsy SouthernPhysician AssistantWinston Salem, NC165$749K
7Kristyn HarePhysician AssistantMiddleton, WI169$726K
8Kristy DarnellNurse PractitionerMerrillville, IN160$721K
9Jennifer KellyInternal MedicineSouth Burlington, VT220$647K
10Linda RussellRheumatologyNew York, NY135$619K
11Jessica StarrInternal MedicineBronx, NY233$612K
12Jennifer TalevskiNurse PractitionerNew York, NY135$603K
13Leah PrestboFamily PracticeSioux Falls, SD126$555K
14Jennifer KellyInternal MedicineSouth Burlington, VT110$517K
15Joseph LaneOrthopedic SurgeryNew York, NY114$509K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
111Lenvatinib Mesylate (Lenvima)$164.6M7,004
112Treprostinil (Tyvaso Dpi)$158.9M6,704
113Rimegepant Sulfate (Nurtec Odt)$155.0M106,692
114Teriparatide (Forteo)$153.9M38,259
115Ixekizumab (Taltz Autoinjector)$149.8M19,972
116Sofosbuvir/Velpatasvir (Epclusa)$149.4M6,544
117Dolutegravir/Rilpivirine (Juluca)$148.9M41,081

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology